Sartorius Stedim Biotech SA (DIM) — Cash Flow Reinvestment Rate
Sartorius Stedim Biotech SA (DIM) has a Cash Flow Reinvestment Rate of 0.56x as of June 2026, reinvesting €72.80 Million (capex €72.80 Million ) from operating cash flow of €129.50 Million. See Sartorius Stedim Biotech SA (DIM) free cash flow to measure how efficiently the company converts operating cash flow to free cash.
Reinvestment Rate
Total Reinvested
Operating Cash Flow
Capital Expenditures
Sartorius Stedim Biotech SA Cash Flow Reinvestment Rate (2005–2025)
Historical reinvestment intensity for Sartorius Stedim Biotech SA across 21 annual periods. For the full cash flow conversion analysis, see Sartorius Stedim Biotech SA (DIM) cash conversion ratio.
Annual Cash Flow Reinvestment Rate for Sartorius Stedim Biotech SA (2005–2025)
Year-by-year capital reinvestment analysis for Sartorius Stedim Biotech SA. See Sartorius Stedim Biotech SA (DIM) financial flexibility to measure the company's free cash flow as a share of total liabilities.
| Year | Reinvestment Rate | Total Reinvested (EUR) | Operating CF | Capex | YoY Change |
|---|---|---|---|---|---|
| 2025 | 0.74x | €397.60 Million | €538.60 Million | €393.20 Million | ▼ -11.5% |
| 2024 | 0.83x | €679.80 Million | €815.10 Million | €339.80 Million | ▼ -80.8% |
| 2023 | 4.35x | €3.24 Billion | €746.40 Million | €473.60 Million | ▲ +91.7% |
| 2022 | 2.27x | €1.39 Billion | €612.30 Million | €430.60 Million | ▲ +99.9% |
| 2021 | 1.13x | €789.21 Million | €695.97 Million | €323.99 Million | ▼ -39.4% |
| 2020 | 1.87x | €780.31 Million | €416.88 Million | €159.19 Million | ▲ +80.9% |
| 2019 | 1.03x | €320.87 Million | €310.13 Million | €135.97 Million | ▼ -33.4% |
| 2018 | 1.55x | €353.08 Million | €227.29 Million | €176.54 Million | ▼ -15.7% |
| 2017 | 1.84x | €321.75 Million | €174.69 Million | €126.83 Million | ▲ +58.2% |
| 2016 | 1.16x | €182.45 Million | €156.66 Million | €79.71 Million | ▲ +213.8% |
| 2015 | 0.37x | €52.98 Million | €142.79 Million | €52.98 Million | ▼ -12.2% |
| 2014 | 0.42x | €47.07 Million | €111.31 Million | €47.07 Million | ▲ +30.1% |
| 2013 | 0.32x | €29.28 Million | €90.11 Million | €29.28 Million | ▼ -59.0% |
| 2012 | 0.79x | €38.78 Million | €48.93 Million | €38.78 Million | ▲ +24.6% |
| 2011 | 0.64x | €38.55 Million | €60.59 Million | €38.55 Million | ▲ +177.5% |
| 2010 | 0.23x | €16.68 Million | €72.76 Million | €16.68 Million | ▲ +31.3% |
| 2009 | 0.17x | €16.05 Million | €91.86 Million | €16.05 Million | ▼ -59.2% |
| 2008 | 0.43x | €20.23 Million | €47.23 Million | €20.23 Million | ▼ -18.5% |
| 2007 | 0.53x | €13.68 Million | €26.02 Million | €13.68 Million | ▼ -12.9% |
| 2006 | 0.60x | €31.21 Million | €51.72 Million | €31.21 Million | ▲ +91.9% |
| 2005 | 0.31x | €13.79 Million | €43.85 Million | €13.79 Million | — |